These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 23163689)
1. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. Crawford NW; Cheng A; Andrews N; Charles PG; Clothier HJ; Day B; Day T; Gates P; Macdonell R; Roberts L; Rodriguez-Casero V; Wijeratne T; Kiers L Med J Aust; 2012 Nov; 197(10):574-8. PubMed ID: 23163689 [TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database. Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J; BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524 [TBL] [Abstract][Full Text] [Related]
3. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec. De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419 [TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. Romio S; Weibel D; Dieleman JP; Olberg HK; de Vries CS; Sammon C; Andrews N; Svanström H; Mølgaard-Nielsen D; Hviid A; Lapeyre-Mestre M; Sommet A; Saussier C; Castot A; Heijbel H; Arnheim-Dahlström L; Sparen P; Mosseveld M; Schuemie M; van der Maas N; Jacobs BC; Leino T; Kilpi T; Storsaeter J; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC PLoS One; 2014; 9(1):e82222. PubMed ID: 24404128 [TBL] [Abstract][Full Text] [Related]
5. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses. Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672 [TBL] [Abstract][Full Text] [Related]
6. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H; Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307 [TBL] [Abstract][Full Text] [Related]
7. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome. Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755 [TBL] [Abstract][Full Text] [Related]
8. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Greene SK; Rett M; Weintraub ES; Li L; Yin R; Amato AA; Ho DT; Sheikh SI; Fireman BH; Daley MF; Belongia EA; Jacobsen SJ; Baxter R; Lieu TA; Kulldorff M; Vellozzi C; Lee GM Am J Epidemiol; 2012 Jun; 175(11):1100-9. PubMed ID: 22582210 [TBL] [Abstract][Full Text] [Related]
9. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590 [TBL] [Abstract][Full Text] [Related]
10. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010. Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165 [TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Andrews N; Stowe J; Al-Shahi Salman R; Miller E Vaccine; 2011 Oct; 29(45):7878-82. PubMed ID: 21875631 [TBL] [Abstract][Full Text] [Related]
12. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea. Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315 [TBL] [Abstract][Full Text] [Related]
13. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N; Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095 [TBL] [Abstract][Full Text] [Related]
14. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study. Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750 [TBL] [Abstract][Full Text] [Related]
15. Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Prestel J; Volkers P; Mentzer D; Lehmann HC; Hartung HP; Keller-Stanislawski B; Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1192-204. PubMed ID: 24817531 [TBL] [Abstract][Full Text] [Related]
16. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Wise ME; Viray M; Sejvar JJ; Lewis P; Baughman AL; Connor W; Danila R; Giambrone GP; Hale C; Hogan BC; Meek JI; Murphree R; Oh JY; Reingold A; Tellman N; Conner SM; Singleton JA; Lu PJ; DeStefano F; Fridkin SK; Vellozzi C; Morgan OW Am J Epidemiol; 2012 Jun; 175(11):1110-9. PubMed ID: 22582209 [TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011. Greene SK; Rett MD; Vellozzi C; Li L; Kulldorff M; Marcy SM; Daley MF; Belongia EA; Baxter R; Fireman BH; Jackson ML; Omer SB; Nordin JD; Jin R; Weintraub ES; Vijayadeva V; Lee GM PLoS One; 2013; 8(6):e67185. PubMed ID: 23840621 [TBL] [Abstract][Full Text] [Related]
18. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries. Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146 [TBL] [Abstract][Full Text] [Related]
19. Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic. Vellozzi C; Iqbal S; Stewart B; Tokars J; DeStefano F Am J Public Health; 2014 Apr; 104(4):696-701. PubMed ID: 24524517 [TBL] [Abstract][Full Text] [Related]
20. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M; BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]